Warning: The NCBI web site requires JavaScript to function. more...
Characterization of immunoglobulin G antibodies to Plasmodium falciparum sporozoite surface antigen MB2 in malaria exposed individuals.
Nguyen TV, Sacci JB Jr, de la Vega P, John CC, James AA, Kang AS.
Malar J. 2009 Oct 23;8:235.
Related citations
Humoral immune responses in volunteers immunized with irradiated Plasmodium falciparum sporozoites.
Egan JE, Hoffman SL, Haynes JD, Sadoff JC, Schneider I, Grau GE, Hollingdale MR, Ballou WR, Gordon DM.
Am J Trop Med Hyg. 1993 Aug;49(2):166-73.
Molecular dissection of the human antibody response to the structural repeat epitope of Plasmodium falciparum sporozoite from a protected donor.
Chappel JA, Rogers WO, Hoffman SL, Kang AS.
Malar J. 2004 Jul 29;3:28.
Recognition of different domains of the Plasmodium falciparum CS protein by the sera of naturally infected individuals compared with those of sporozoite-immunized volunteers.
Calle JM, Nardin EH, Clavijo P, Boudin C, Stüber D, Takacs B, Nussenzweig RS, Cochrane AH.
J Immunol. 1992 Oct 15;149(8):2695-701.
Plasmodium falciparum sporozoite invasion is inhibited by naturally acquired or experimentally induced polyclonal antibodies to the STARP antigen.
Pasquetto V, Fidock DA, Gras H, Badell E, Eling W, Ballou WR, Belghiti J, Tartar A, Druilhe P.
Eur J Immunol. 1997 Oct;27(10):2502-13. Erratum in: Eur J Immunol 1997 Nov;27(11):3084.
The antibody response to Plasmodium falciparum Merozoite Surface Protein 4: comparative assessment of specificity and growth inhibitory antibody activity to infection-acquired and immunization-induced epitopes.
de Silva HD, Saleh S, Kovacevic S, Wang L, Black CG, Plebanski M, Coppel RL.
Malar J. 2011 Sep 16;10:266.
Successful immunization of humans with irradiated malaria sporozoites: humoral and cellular responses of the protected individuals.
Herrington D, Davis J, Nardin E, Beier M, Cortese J, Eddy H, Losonsky G, Hollingdale M, Sztein M, Levine M, et al.
Am J Trop Med Hyg. 1991 Nov;45(5):539-47.
Antibody responses to Plasmodium falciparum sporozoite-, liver- and blood-stage synthetic peptides in migrant and autochthonous populations in malaria endemic areas.
Ferreira-da-Cruz MF, Deslandes DC, Oliveira-Ferreira J, Montenegro-James S, Tartar A, Druilhe P, Daniel-Ribeiro CT.
Parasite. 1995 Mar;2(1):23-9.
Plasmodium falciparum sporozoite immunization protects against Plasmodium berghei sporozoite infection.
Sina BJ, do Rosario VE, Woollett G, Sakhuja K, Hollingdale MR.
Exp Parasitol. 1993 Sep;77(2):129-35.
Immunogenicity of a recombinant malaria vaccine candidate, domain I+II of AMA-1 ectodomain, from Indian P. falciparum alleles.
Lalitha PV, Biswas S, Pillai CR, Saxena RK.
Vaccine. 2008 Aug 18;26(35):4526-35. Epub 2008 Jun 30.
A conserved peptide sequence of the Plasmodium falciparum circumsporozoite protein and antipeptide antibodies inhibit Plasmodium berghei sporozoite invasion of Hep-G2 cells and protect immunized mice against P. berghei sporozoite challenge.
Chatterjee S, Wery M, Sharma P, Chauhan VS.
Infect Immun. 1995 Nov;63(11):4375-81.
Antibodies from malaria-exposed pregnant women recognize trypsin resistant epitopes on the surface of Plasmodium falciparum-infected erythrocytes selected for adhesion to chondroitin sulphate A.
Sharling L, Enevold A, Sowa KM, Staalsoe T, Arnot DE.
Malar J. 2004 Sep 6;3:31.
IgG(4) Pf NPNA-1 a human anti-Plasmodium falciparum sporozoite monoclonal antibody cloned from a protected individual inhibits parasite invasion of hepatocytes.
Chappel JA, Hollingdale MR, Kang AS.
Hum Antibodies. 2004;13(3):91-6.
Development of two monoclonal antibodies against Plasmodium falciparum sporozoite surface protein 2 and mapping of B-cell epitopes.
Charoenvit Y, Fallarme V, Rogers WO, Sacci JB Jr, Kaur M, Aguiar JC, Yuan LF, Corradin G, Andersen E, Wizel B, Houghten RA, Oloo A, De la Vega P, Hoffman SL.
Infect Immun. 1997 Aug;65(8):3430-7.
Irradiated sporozoite vaccine induces HLA-B8-restricted cytotoxic T lymphocyte responses against two overlapping epitopes of the Plasmodium falciparum sporozoite surface protein 2.
Wizel B, Houghten RA, Parker KC, Coligan JE, Church P, Gordon DM, Ballou WR, Hoffman SL.
J Exp Med. 1995 Nov 1;182(5):1435-45.
Antibodies and reactive T cells against the malaria heat-shock protein Pf72/Hsp70-1 and derived peptides in individuals continuously exposed to Plasmodium falciparum.
Behr C, Sarthou JL, Rogier C, Trape JF, Dat MH, Michel JC, Aribot G, Dieye A, Claverie JM, Druihle P, et al.
J Immunol. 1992 Nov 15;149(10):3321-30.
Reactivity profile of human anti-82-kilodalton rhoptry protein antibodies generated during natural infection with Plasmodium falciparum.
Howard RF, Jensen JB, Franklin HL.
Infect Immun. 1993 Jul;61(7):2960-5.
Naturally acquired IgG antibodies against the C-terminal part of Plasmodium falciparum sporozoite threonine-asparagine-rich protein in a low endemic area.
Suwancharoen C, Putaporntip C, Rungruang T, Jongwutiwes S.
Parasitol Res. 2011 Aug;109(2):315-20. Epub 2011 Feb 1.
Safety, immunogenicity, and efficacy of a Plasmodium falciparum vaccine comprising a circumsporozoite protein repeat region peptide conjugated to Pseudomonas aeruginosa toxin A.
Fries LF, Gordon DM, Schneider I, Beier JC, Long GW, Gross M, Que JU, Cryz SJ, Sadoff JC.
Infect Immun. 1992 May;60(5):1834-9.
Immune response and lack of immune response to Plasmodium falciparum P126 antigen and its amino-terminal repeat in malaria-infected humans.
Banic DM, de Oliveira-Ferreira J, Pratt-Riccio LR, Conseil V, Gonçalves D, Fialho RR, Gras-Masse H, Daniel-Ribeiro CT, Camus D.
Am J Trop Med Hyg. 1998 Jun;58(6):768-74.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on